@article{92c366f81cb543019601fc4452cf6539,
title = "Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure",
abstract = "Use of new biomarkers in the handling of heart failure patients has been advocated in the literature, but most often in hospital-based populations. Therefore, we wanted to evaluate whether plasma measurement of N-terminal pro-B-type natriuretic peptide (NT-proBNP), midregional pro-A-type natriuretic peptide (MR-proANP), and midregional proadrenomedullin (MR-proADM), individually or combined, gives prognostic information regarding cardiovascular and all-cause mortality that could motivate use in elderly patients presenting with symptoms suggestive of heart failure in primary health care.",
keywords = "Adrenomedullin, Aged, Aged, 80 and over, Biological Markers, Cohort Studies, Disease Progression, Female, Follow-Up Studies, Heart Failure, Humans, Kaplan-Meier Estimate, Male, Natriuretic Peptide, Brain, Normal Distribution, Peptide Fragments, Primary Health Care, Proportional Hazards Models, Protein Precursors, Risk Assessment, Sensitivity and Specificity, Survival Analysis, Sweden, Time Factors",
author = "Urban Alehagen and Ulf Dahlstr{\"o}m and Rehfeld, {Jens F} and Goetze, {Jens P}",
note = "Copyright {\textcopyright} 2013 Elsevier Inc. All rights reserved.",
year = "2013",
month = jan,
doi = "10.1016/j.cardfail.2012.11.002",
language = "English",
volume = "19",
pages = "31--9",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "1",
}